EC approves amendment of Valneva’s Covid-19 vaccines purchase deal
The EC member states will now buy 1.25 million doses of VLA2001 this year after amending the previous purchase deal.

The EC member states will now buy 1.25 million doses of VLA2001 this year after amending the previous purchase deal.
The lawsuit was filed against BioNTech and two of its subsidiaries in the German Regional Court in Düsseldorf.
KIN001 acts on the host cell pathways required for the replication of the virus.
The alpha-1 antitrypsin deficiency (AATD) market in the US and Germany is expected to see significant growth from 2021 to…
ByBioNTech will make an upfront payment of $29.5m to Medigene, which will also receive research funding.
The OECD believes that the strong rebound after the Covid-19 economic crisis in 2020 may soon moderate in several major…
Covid-19 NanoAbs demonstrated to have robust competitive advantage against current Covid-19 drugs.
Boehringer Ingelheim will contribute its research and drugs development expertise for advancing medications into the clinic.
Thank you for subscribing to Pharmaceutical Technology